These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
381 related items for PubMed ID: 25584710
1. Relationship between Overall Survival of Patients with Non-Small Cell Lung Cancer and Whole-Body Metabolic Tumor Burden Seen on Postsurgical Fluorodeoxyglucose PET Images. Zhang C, Liao C, Penney BC, Appelbaum DE, Simon CA, Pu Y. Radiology; 2015 Jun; 275(3):862-9. PubMed ID: 25584710 [Abstract] [Full Text] [Related]
2. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer. Zhang H, Wroblewski K, Liao S, Kampalath R, Penney BC, Zhang Y, Pu Y. Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369 [Abstract] [Full Text] [Related]
4. Prognostic value of quantitative PET/CT in patients with a nonsmall cell lung cancer and another primary cancer. Zhu X, Liao C, Penney BC, Li F, Ferguson MK, Simon CA, Wu T, Liu H, Pu Y. Nucl Med Commun; 2017 Feb; 38(2):185-192. PubMed ID: 27922540 [Abstract] [Full Text] [Related]
6. A new PET/CT volumetric prognostic index for non-small cell lung cancer. Zhang H, Wroblewski K, Jiang Y, Penney BC, Appelbaum D, Simon CA, Salgia R, Pu Y. Lung Cancer; 2015 Jul; 89(1):43-9. PubMed ID: 25936471 [Abstract] [Full Text] [Related]
11. Prognostic value of tumor burden measurement using the number of tumors in non-surgical patients with non-small cell lung cancer. Zhang H, Wroblewski K, Pu Y. Acta Radiol; 2012 Jun 01; 53(5):561-8. PubMed ID: 22661603 [Abstract] [Full Text] [Related]
14. Whole body metabolic tumor volume is a prognostic marker in patients with newly diagnosed stage 3B non-small cell lung cancer, confirmed with external validation. Dashevsky BZ, Zhang C, Yan L, Yuan C, Xiong L, Liu Y, Liu H, Kong FS, Pu Y. Eur J Hybrid Imaging; 2017 Jun 01; 1(1):8. PubMed ID: 29782599 [Abstract] [Full Text] [Related]
15. The Volume-metabolic Combined Parameters from (18)F-FDG PET/CT May Help Predict the Outcomes of Cervical Carcinoma. Sun Y, Lu P, Yu L. Acad Radiol; 2016 May 01; 23(5):605-10. PubMed ID: 26853968 [Abstract] [Full Text] [Related]
16. Three-way Comparison of Whole-Body MR, Coregistered Whole-Body FDG PET/MR, and Integrated Whole-Body FDG PET/CT Imaging: TNM and Stage Assessment Capability for Non-Small Cell Lung Cancer Patients. Ohno Y, Koyama H, Yoshikawa T, Takenaka D, Seki S, Yui M, Yamagata H, Aoyagi K, Matsumoto S, Sugimura K. Radiology; 2015 Jun 01; 275(3):849-61. PubMed ID: 25584709 [Abstract] [Full Text] [Related]
17. Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer. Kim K, Kim SJ, Kim IJ, Kim YS, Pak K, Kim H. Nucl Med Commun; 2012 Jun 01; 33(6):613-20. PubMed ID: 22407127 [Abstract] [Full Text] [Related]